Rosen Law Firm has issued an urgent reminder for investors who purchased Altimmune shares between August 10, 2023, and June 25, 2025. The October 6, 2025 deadline to seek lead plaintiff status in a class action lawsuit could be key for those seeking compensation.

The Rosen Law Firm, P.A., has issued a notice encouraging KBR, Inc. investors to explore a possible securities class action investigation. The announcement comes from a September 15, 2025, report, signaling potential rights or claims for shareholders.

The Rosen Law Firm is urging current and former investors of Simulations Plus, Inc. to inquire about a potential securities class action. The announcement, released on September 12, 2025, suggests there may be legal implications affecting shareholders.

Novo Nordisk A/S shareholders who purchased their securities between May 7, 2025, and July 28, 2025, are advised by Rosen Law Firm to consider legal action. With the lead plaintiff deadline set for September 30, 2025, investors are encouraged to act promptly to secure potential compensation.

The Rosen Law Firm has called upon investors of TechTarget, Inc. to inquire about a securities class action investigation concerning the company.

Investors who purchased American Depositary Shares of Reckitt Benckiser between January 13, 2021, and July 28, 2024, may have the opportunity to lead a securities fraud class action lawsuit. Rosen Law Firm has filed the suit, and the deadline to move the court to serve as lead plaintiff is August 4, 2025.